There was clear evidence that there was a massive reduction in osteoporosis and fracture. For women aged 50 to 59 who went in the study, there was no increased risk of cardiovascular disease. It's the only medication ever shown to dramatically reduce fracture rates in women without osteoporotic. There was an increased risk of thrombosis, deep vein thrombotes, which occurred mostly in the first 18 months of use.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode